CLINICAL EFFICIENCY OF VACCINATION, ERDOSTEINE AND PULMONARY REHABILITATION IN THE PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS
https://doi.org/10.21292/2075-1230-2016-94-11-44-49
Abstract
Goal of the study: to evaluate the clinical efficiency of anti-influenza vaccination, erdosteine and pulmonary rehabilitation for prevention of exacerbations in COPD patients.
Materials and methods. 108 patients suffering from COPD of medium severity (average age 50.48 ± 0.88 years old) and receiving standard therapy for their main condition were enrolled into the study. The results were evaluated in 12 months by the software titled Management System for Treatment and Diagnostics of Those Suffering from Asthma and Chronic Obstructive Pulmonary Disease (Pulmosys).
Results. This set of measures demonstrated confidently high clinical efficiency: anti-influenza vaccination, erdosteine and pulmonary rehabilitation compared to standard therapy, and compared to vaccination and pulmonary rehabilitation with standard therapy. Clinical efficiency manifested through confident reduction in the number of exacerbations and admissions to hospital, positive changes in the clinical signs of COPD, confident reduction of the system biomarkers' level, increased tolerance to physical load, and enhancement in the life quality of the patients.
About the Authors
A. V. BudnevskiyRussian Federation
Doctor of Medical Sciences, Professor, Prorector for Innovative Research Activities, Head of Faculty Therapy Department,
10, Studencheskaya St., Voronezh, 394036
E. S. Ovsyannikov
Russian Federation
Candidate of Medical Sciences, Associate Professor of Faculty Therapy Department,
10, Studencheskaya St., Voronezh, 394036
A. V. Pertsev
Russian Federation
Post Graduate Student of Faculty Therapy Department,
10, Studencheskaya St., Voronezh, 394036
S. A. Kozhevnikova
Russian Federation
Candidate of Medical Sciences, Assistant of Therapy Department by Professional Development Institute,
10, Studencheskaya St., Voronezh, 394036
References
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD, Revision of 2014), (Epub.) – (http://www.goldcopd.org).
2. Danyshbaeva A.B. Role of educational and anti-smoking programs in the prevention of chronic obstructive pulmonary disease, Vestn. Kazakh. Nats. Med. Universiteta, 2013, no. 2, pp. 24-26. (In Russ.)
3. Pertsev А.V., Budaeva E.А., Filina N.V. Efficiency of prevention of chronic obstructive pulmonary disease exacerbation with the use of erdosteine. Molodoy Ucheny, 2014, no. 17, pp. 168-173. (In Russ.)
4. Pronin S.S., Budnevskiy А.V., Burlachuk V.T. et al. Sistema monitoringa patsientov s khronicheskoy obstruktivnoy bolezn'yu legkikh. [Monitoring system of chronic obstructive pulmonary disease patients]. Software registration certificate no. 2015614261. Registered as of 13.04.2015. p. 1.
5. Smirnov V.Yu. Mucolytics in pathogenic therapy of chronic bronchial pulmonary diseases. FARMindeks: Praktik, 2014, no. 6, pp. 24-29. (In Russ.)
6. Chebykina А.V., Kostinov M.P. Role of anti-influenza vaccination in the prevention of chronic obstructive pulmonary disease exacerbations. Atmosphera. Pul'monologiya i Otorinolaringologiya, 2012, no. 4, pp. 3-5. (In Russ.)
7. Moretti M. Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease. Expert. Rev. Resp. Med., 2007, no. 1, pp. 307-316.
Review
For citations:
Budnevskiy A.V., Ovsyannikov E.S., Pertsev A.V., Kozhevnikova S.A. CLINICAL EFFICIENCY OF VACCINATION, ERDOSTEINE AND PULMONARY REHABILITATION IN THE PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS. Tuberculosis and Lung Diseases. 2016;94(11):44-49. (In Russ.) https://doi.org/10.21292/2075-1230-2016-94-11-44-49